The Neuroprotective Effect of Overexpression of Calbindin-D28k in an Animal Model of Parkinson’s Disease

被引:0
作者
Hong-Hua Yuan
Ren-Jin Chen
Yu-Hua Zhu
Chang-Ling Peng
Xiao-Rong Zhu
机构
[1] Xuzhou Medical College,Department of Neurobiology
[2] Xuzhou Medical College,Experimental Animal Center
来源
Molecular Neurobiology | 2013年 / 47卷
关键词
Calbindin-D; Dopamine; Parkinson’s disease; Transgenic mice;
D O I
暂无
中图分类号
学科分类号
摘要
Overexpression of calbindin-D28k (CaBP-28 k) induces neurite outgrowth in dopaminergic neuronal cells and could provide some protection to dopaminergic neurons against the pathological process in Parkinson’s disease. Transgenic mice CaBP-28 k overexpression and the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse models were generated, and the effect of midbrain dopamine neurons in ethology was also assessed. Tyrosine hydroxylase (TH)-immunoreactive neurons were counted, and the concentration of total protein and dopamine (DA) of striatum corpora was measured in four animal models. Results showed that the positive TH cells, content of DA, and ability of ethology in MPTP-induced transgenic mice were significantly higher than that in MPTP-induced wild-type mice. The findings demonstrate that overexpression of CaBP-28 k could provide protection for DA neurons from neurodegeneration. It would provide a potential strategy in the treatment of Parkinson’s diseases.
引用
收藏
页码:117 / 122
页数:5
相关论文
共 50 条
  • [1] The Neuroprotective Effect of Overexpression of Calbindin-D28k in an Animal Model of Parkinson's Disease
    Yuan, Hong-Hua
    Chen, Ren-Jin
    Zhu, Yu-Hua
    Peng, Chang-Ling
    Zhu, Xiao-Rong
    MOLECULAR NEUROBIOLOGY, 2013, 47 (01) : 117 - 122
  • [2] Fractionally delineate the neuroprotective function of calbindin-D28k in Parkinson's disease
    Joshi, Hardik
    Jha, Brajesh Kumar
    INTERNATIONAL JOURNAL OF BIOMATHEMATICS, 2018, 11 (08)
  • [3] Role of calbindin-D28K in estrogen treatment for Parkinson’s disease
    Chunhua Wang
    Chao Jiang
    Honghua Yuan
    Chenghua Xiao
    Dianshuai Gao
    NeuralRegenerationResearch, 2013, 8 (08) : 702 - 707
  • [4] Role of calbindin-D28K in estrogen treatment for Parkinson's disease
    Wane, Chunhua
    Jiang, Chao
    Yuan, Honghua
    Xiao, Chenghua
    Gao, Dianshuai
    NEURAL REGENERATION RESEARCH, 2013, 8 (08) : 702 - 707
  • [5] Suppression of Calbindin-D28k Expression Exacerbates SCA1 Phenotype in a Disease Mouse Model
    Vig, Parminder J. S.
    Wei, Jinrong
    Shao, Qingmei
    Lopez, Maripar E.
    Halperin, Rebecca
    Gerber, Jill
    CEREBELLUM, 2012, 11 (03) : 718 - 732
  • [6] Intracellular calcium ion response to glucose in β-cells of calbindin-D28k nullmutant mice and in βHC13 cells overexpressing calbindin-D28k
    Jai Parkash
    Muhammad A. Chaudhry
    Ayman S. Amer
    Sylvia Christakos
    William B. Rhoten
    Endocrine, 2002, 18 : 221 - 229
  • [7] Thymoquinone exerts neuroprotective effect in animal model of Parkinson's disease
    Ebrahimi, Seyedeh Shohreh
    Oryan, Shahrbanoo
    Izadpanah, Esmael
    Hassanzadeh, Kambiz
    TOXICOLOGY LETTERS, 2017, 276 : 108 - 114
  • [8] Regulation of Calbindin-D28k Expression by Msx2 in the Dental Epithelium
    Bolanos, Alba
    Hotton, Dominique
    Ferbus, Didier
    Loiodice, Sophia
    Berdal, Ariane
    Babajko, Sylvie
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2012, 60 (08) : 603 - 610
  • [9] EVIDENCE FOR THE INVOLVEMENT OF CALBINDIN D28k IN THE PRESENILIN 1 MODEL OF ALZHEIMER'S DISEASE
    Odero, G. L.
    Oikawa, K.
    Glazner, K. A. C.
    Schapansky, J.
    Grossman, D.
    Thiessen, J. D.
    Motnenko, A.
    Ge, N.
    Martin, M.
    Glazner, G. W.
    Albensi, B. C.
    NEUROSCIENCE, 2010, 169 (01) : 532 - 543
  • [10] RELATIVE SPARING IN PARKINSONS-DISEASE OF SUBSTANTIA-NIGRA DOPAMINE NEURONS CONTAINING CALBINDIN-D28K
    YAMADA, T
    MCGEER, PL
    BAIMBRIDGE, KG
    MCGEER, EG
    BRAIN RESEARCH, 1990, 526 (02) : 303 - 307